Data cleaning and preparation algorithm. by Ayana Ablayeva (22103708)

Subjects:

PRCC values (with <i>p</i>-values in parentheses) for the median final population size and difference in mean MSI at the final time, without weevil predation and with weevil predat... by Alexandra M. Campbell (3284094)

Subjects:

Distribution of final population size (A) and mean change in mean MSI over time (B) over 100 simulations for each parameter set shown in Table 3 in the absence of weevils (left) an... by Alexandra M. Campbell (3284094)

Subjects:

Mean interval from initial diagnosis to initiation of non-pharmacological treatment by year. by Mingee Choi (15250732)

Subjects: “…treatment initiation decreased…”

Comparison of training and predicted values of compound water solubility for different machine learning models: (A) AdaBoost, (B) GBDT, (C) LGBM, (D) RF, (E) XGBoost, (F) RF, and (... by Bin Pan (742525)

Subjects:

Synthetic feasibility scores of 20 molecular fragments. by Bin Pan (742525)

Subjects:

The scatter plot of the target variable solubility dataset. by Bin Pan (742525)

Subjects:

Samples with the highest solubility after high-throughput screening. by Bin Pan (742525)

Subjects:

Assessment values of machine learning models. by Bin Pan (742525)

Subjects:

List of datasets in AqSolDB. by Bin Pan (742525)

Subjects:

Schematic workflow diagram of the StackBoost model framework. by Bin Pan (742525)

Subjects:

Pearson correlation analysis between pairs of feature parameters. by Bin Pan (742525)

Subjects:

List of available information in each column of AqSolDB. by Bin Pan (742525)

Subjects:

3D Scatter plot of features related to water-soluble materials. by Bin Pan (742525)

Subjects:

Feature importance derived from SHAP analysis. by Bin Pan (742525)

Subjects:

Socio-demographic characteristics of women in study sample (means except as noted). by Chelsea Ducille (21540080)

Subjects:

Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during letrozole treatment. by Kazuyoshi Ohkawa (836847)

Subjects:

Flowchart of patient selection in this study. by Kazuyoshi Ohkawa (836847)

Subjects:

Changes in the FIB-4 index in breast cancer patients with a FIB-4 index of ≥ 2.67 during letrozole and anastrozole treatment. by Kazuyoshi Ohkawa (836847)

Subjects:

Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during anastrozole treatment. by Kazuyoshi Ohkawa (836847)

Subjects: